Advertisement
Screener

PDS Biotechnology Corp (PDSB) Cash Flow Breakdown

2.8 / 5 stars · 68/120 Roast Me

PDS Biotechnology Corp Cash Flow Breakdown

Cash flow breakdown shows where PDS Biotechnology Corp's cash came from and where it went: from running the business, from investing (buying or selling equipment, companies and investments) and from financing (borrowing, paying back loans, buying back shares, paying dividends). One row per year or quarter. A minus sign means cash went out. Financing is shown line by line: buybacks, dividends, debt paid back, new debt and the rest. All amounts are the filed figures for that period.

  • Fiscal year ended 2025-12-31: from running the business, $27.75M went out.
  • Fiscal year ended 2025-12-31: from investing, $0.00 came in.
  • Fiscal year ended 2025-12-31: from financing, $12.77M came in.
  • Fiscal year ended 2025-12-31: change in cash, $14.98M went out.

A minus sign means cash went out. * = worked out from the filed year-to-date figures (hover to see how); greyed = already counted inside another line.

Each year (12 month)

Fiscal year endRunning the businessFrom investingDebt paid backStaff share taxNew shares soldNot split outChange in cash
2025-12-31-$27.75M$0.00-$19.00M$9.71M$22.07M*-$14.98M
2024-12-31-$35.03M-$29.00K$0.00$0.00$20.19M*-$14.87M
2023-12-31-$33.64M$0.00$0.00$16.13M-$17.26M
2022-12-31-$25.71M-$270.96K$9.86M$24.70M*$8.58M
2021-12-31-$12.49M$0.00$48.54M$36.40M
2020-12-31-$13.15M$0.00$29.76M$16.68M
2019-12-31-$18.07M$29.38M$750.00K$12.06M
2018-12-31-$1.57M$0.00$1.28M-$53.42M
2017-12-31-$40.70M-$188.72K$118.19K$22.44M*-$18.33M
2016-12-31-$32.19M-$686.71K$293.99K$8.79M*-$23.79M
2015-12-31-$21.75M-$1.31M$1.09K$139.52M*$116.46M
2014-12-31-$9.72M-$884.79K$0.00$16.47M*$5.87M
2013-12-31-$8.04M-$136.89K$0.00$15.90M*$7.72M

Each quarter (3 month)

Quarter endRunning the businessFrom investingDebt paid backNew shares soldNot split outChange in cash
2026-06-30-$2.79M*$0.00*-$13.27M*
2026-03-31-$4.37M$0.00-$679.83K*-$5.05M
2025-12-31-$3.70M*$0.00*-$354.17K*$2.71M*$1.86M*
2025-09-30-$5.92M*$0.00*$0.00*$0.00*
2025-06-30-$9.10M*$0.00*$995.94K*
2025-03-31-$9.03M$6.99M-$1.71M
2024-12-31-$8.23M*$0.00*$0.00*$0.00*
2024-09-30-$8.00M*-$1.00*$0.00*$0.00*
2024-06-30-$8.86M*$0.00
2024-03-31-$9.94M$0.00$20.01M*$10.07M
2023-12-31-$8.46M*$0.00*$10.48M*
2023-09-30-$7.18M*$0.00*$800.00K
2023-06-30-$4.81M*$200.00K
2023-03-31-$13.19M$4.59M-$8.62M
2022-12-31-$7.53M*$9.86M*
2022-09-30-$5.89M*$0.00*$24.55M*
2022-06-30-$5.92M*$0.00*
2022-03-31-$6.37M$0.00-$6.36M
2021-12-31-$4.50M*$0.00*
2021-09-30-$5.13M*$0.00*
2021-06-30$946.23K*$48.54M*
2021-03-31-$3.80M$0.00-$3.80M
2020-12-31-$4.63M*$0.00*$0.00*
2020-09-30-$1.25M*$0.00*$17.79M*
2020-06-30-$4.10M*$0.00*$0.00*
2020-03-31-$3.16M$0.00$11.97M$8.88M
2019-12-31-$5.52M*$275.00K*$0.00*
2019-09-30-$4.33M*$0.00*$0.00*
2019-06-30-$4.86M*$0.00*$0.00*
2019-03-31-$3.37M$29.11M$750.00K$26.49M
2018-12-31-$317.63K*$0.00*$50.63K*-$2.17M*
2018-09-30-$432.25K*$0.00*$173.37K*-$9.16M*
2018-06-30-$415.37K*$0.00*$3.00*-$29.02M*
2018-03-31-$404.34K$0.00$1.06M-$13.07M
2017-12-31-$9.24M*-$27.97K*$26.21K*-$9.24M*
2017-09-30-$11.40M*-$55.09K*$0.00*-$11.41M*
2017-06-30-$9.28M*-$16.38K*$41.02K*$22.38M*$13.12M*
2017-03-31-$10.77M-$89.28K$50.96K-$10.81M
2016-12-31-$6.05M*-$347.30K*$0.00*-$6.39M*
2016-09-30-$8.79M*-$144.09K*$267.79K*$10.43M*$1.76M*
2016-06-30-$8.28M*-$118.03K*$25.65K*-$552.80K*-$8.92M*
2016-03-31-$9.07M-$77.29K$546.00-$1.10M*-$10.25M
2015-12-31-$6.78M*-$505.66K*$1.09K*$84.60M*$77.31M*
2015-09-30-$5.00M*-$352.25K*$0.00*-$5.59M*
2015-06-30-$5.71M*-$361.09K*$0.00*$52.24M*$46.17M*
2015-03-31-$4.27M-$86.08K$0.00$2.92M*-$1.43M
2014-12-31-$2.88M*-$619.64K*$14.43M*$10.92M*

Similar stocks

Stock NameCountryMarket CapPE Ratio
SCYNEXIS INC (SCYX)United States$0.045B
Grace Therapeutics, Inc. (GRCE)$0.046B-1.83
VERU INC. (VERU)United States$0.043B-3.93
Werewolf Therapeutics, Inc. (HOWL)United States$0.047B
Kairos Pharma, LTD. (KAPA)United States$0.041B
Dogwood Therapeutics, Inc. (DWTX)United States$0.049B
Lite Strategy, Inc. (LITS)United States$0.049B
Incannex Healthcare Inc. (IXHL)$0.040B-22.32
Elicio Therapeutics, Inc. (ELTX)United States$0.049B
Karyopharm Therapeutics Inc. (KPTI)United States$0.039B-0.98